FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live CIPLA message board: Is CIPLA buy or sell? Should I buy CIPLA shares? Why are CIPLA shares falling? Should I invest in CIPLA stock?

forum

CIPLA Share Price Discussion

Cipla Ltd.
NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Sector: Pharmaceuticals and health care
NewsBot > CIPLA > Post
N
Reputation: 4,817 • Jun 4 2:01 AM
Indian licensees free to price Remdesivir: Gilead
US drug maker to launch own brand of Covid-19 experimental drug in the country next month. Gilead has licensed the drug to four companies — Cipla, Mylan, Hetero and Jubilant Life Sciences — for sale in India, but none of these firms has received approval from the drug controller. most of the four companies are ready with their products and are awaiting nod from the regulator to manufacture and start selling the drug in the country.
The Economic Times
Like
Reply
NSE:CIPLA price when posted: 642.4
Recent posts in CIPLA
N
Reputation: 4,817 • Today 2:03 AM
Covid-19 vaccine: Cipla scales up manufacturing of remdesivir to meet high demand
Besides remdesivir, tocilizumab that Cipla markets under licensing pact with Swiss pharma company Roche is also seeing huge demand
Moneycontrol
Like
Reply
N
Reputation: 4,817 • Today 1:56 AM
India's shortage of remdesivir is easing, to ramp up production: Producer Cipla
Remdesivir, made by U.S.-based Gilead Sciences Inc, has been in high demand globally, and a handful of companies including Cipla are authorised to make and sell generic versions in 127 developing nations.
The Economic Times
Like
Reply
N
Reputation: 4,817 • Today 12:43 PM
Buy Cipla; target of Rs 805: HDFC Securities
HDFC Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 805 in its research report dated August 10, 2020.
Moneycontrol
Like
Reply
N
Reputation: 4,817 • Today 12:43 PM
Neutral Cipla; target of Rs 790: Motilal Oswal
Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 790 in its research report dated August 08, 2020.
Moneycontrol
Like
Reply
N
Reputation: 4,817 • Today 9:58 AM
Reduce Cipla; target of Rs 657: Prabhudas Lilladher
Prabhudas Lilladher recommended reduce rating on Cipla with a target price of Rs 657 in its research report dated August 09, 2020.
Moneycontrol
Like
Reply
R
Reputation: -612 • Today 8:12 AM

Type
Buy
Instrument
CIPLA
Entry Price
₹776.5
Price@Trade
₹776.5
Target Price
₹780
Stop Price
₹774
Valid Till
Aug 11, 2020 3:20 AM
Margin
₹776,500 approx for 1000 Qty
Status
Exited
Exit Price
₹775.95
Net P&L
-₹550 (-0.07%)
Like
Reply (1)